Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 1993 Mar 1;290(Pt 2):401–404. doi: 10.1042/bj2900401

Effect of saposins on acid sphingomyelinase.

M Tayama 1, S Soeda 1, Y Kishimoto 1, B M Martin 1, J W Callahan 1, M Hiraiwa 1, J S O'Brien 1
PMCID: PMC1132287  PMID: 8452527

Abstract

The effect of saposins (A, B, C and D) on acid sphingomyelinase activity was determined using a crude human kidney sphingomyelinase preparation and a purified sphingomyelinase preparation from human placenta. Saposin D stimulated the activity of the crude enzyme by increasing its apparent Km and Vmax. values for sphingomyelin hydrolysis. Unlike the crude enzyme, the activity of the purified enzyme was strongly inhibited by saposin D as well as other saposins. Saposin D decreased the apparent Km and Vmax values of purified sphingomyelinase activity. The effects of saposin D on the activity of different sphingomyelinase preparations appear to depend on Triton X-100, which is present in the crude enzyme but not in the purified enzyme. When the detergent was removed from the crude preparation, the effect of saposin D changed from being stimulatory to inhibitory. Conversely, when the detergent is added to the purified enzyme, the effect of saposin D on sphingomyelinase activity changed from being inhibitory to stimulatory. While other saposins were inhibitory or had no effect on sphingomyelinase activity in the above assay system, not only saposin D but also saposins A and C exhibited a stimulatory effect upon purified sphingomyelinase activity when the substrate, sphingomyelin, was added in the form of liposomes without detergent. Saposin B was not only inhibitory in the liposome system, but also reduced the stimulatory effect of saposins A, C and D. These observations indicate that the stimulatory effect of saposins A, C and D on acid sphingomyelinase activity is greatly influenced by the physical environment of the enzyme and suggest that similar effects by saposins may be exerted in lysosomal membranes.

Full text

PDF
401

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Christomanou H. Niemann-Pick disease, Type C: evidence for the deficiency of an activating factor stimulating sphingomyelin and glucocerebroside degradation. Hoppe Seylers Z Physiol Chem. 1980 Oct;361(10):1489–1502. doi: 10.1515/bchm2.1980.361.2.1489. [DOI] [PubMed] [Google Scholar]
  2. Hannun Y. A., Bell R. M. Functions of sphingolipids and sphingolipid breakdown products in cellular regulation. Science. 1989 Jan 27;243(4890):500–507. doi: 10.1126/science.2643164. [DOI] [PubMed] [Google Scholar]
  3. Hiraiwa M., Uda Y. Purification and properties of GM1 ganglioside beta-galactosidases from bovine brain. J Biochem. 1986 Sep;100(3):707–715. doi: 10.1093/oxfordjournals.jbchem.a121763. [DOI] [PubMed] [Google Scholar]
  4. Jones C. S., Shankaran P., Callahan J. W. Purification of sphingomyelinase to apparent homogeneity by using hydrophobic chromatography. Biochem J. 1981 May 1;195(2):373–382. doi: 10.1042/bj1950373. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Merrill A. H., Jr, Jones D. D. An update of the enzymology and regulation of sphingomyelin metabolism. Biochim Biophys Acta. 1990 May 1;1044(1):1–12. doi: 10.1016/0005-2760(90)90211-f. [DOI] [PubMed] [Google Scholar]
  6. Morimoto S., Martin B. M., Kishimoto Y., O'Brien J. S. Saposin D: a sphingomyelinase activator. Biochem Biophys Res Commun. 1988 Oct 14;156(1):403–410. doi: 10.1016/s0006-291x(88)80855-6. [DOI] [PubMed] [Google Scholar]
  7. Morimoto S., Yamamoto Y., O'Brien J. S., Kishimoto Y. Distribution of saposin proteins (sphingolipid activator proteins) in lysosomal storage and other diseases. Proc Natl Acad Sci U S A. 1990 May;87(9):3493–3497. doi: 10.1073/pnas.87.9.3493. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. O'Brien J. S., Kretz K. A., Dewji N., Wenger D. A., Esch F., Fluharty A. L. Coding of two sphingolipid activator proteins (SAP-1 and SAP-2) by same genetic locus. Science. 1988 Aug 26;241(4869):1098–1101. doi: 10.1126/science.2842863. [DOI] [PubMed] [Google Scholar]
  9. Poulos A., Ranieri E., Shankaran P., Callahan J. W. Studies on the activation of the enzymatic hydrolysis of sphingomyelin liposomes. Biochim Biophys Acta. 1984 Apr 18;793(2):141–148. doi: 10.1016/0005-2760(84)90315-1. [DOI] [PubMed] [Google Scholar]
  10. Poulos A., Shankaran P., Jones C. S., Callahan J. W. Enzymatic hydrolysis of sphingomyelin liposomes by normal tissues and tissues from patients with Niemann-Pick disease. Biochim Biophys Acta. 1983 May 16;751(3):428–431. doi: 10.1016/0005-2760(83)90302-8. [DOI] [PubMed] [Google Scholar]
  11. Wenger D. A., Sattler M., Roth S. A protein activator of galactosylceramide beta-galactosidase. Biochim Biophys Acta. 1982 Sep 14;712(3):639–649. doi: 10.1016/0005-2760(82)90293-4. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES